Hospital News and Research

RSS

BiondVax commences Multimeric-001 flu vaccine Phase IIa clinical study

BiondVax Pharmaceuticals Ltd., an Israeli biopharmaceutical company at the forefront of global efforts towards the development of a Universal Influenza Vaccine, today announced that it has begun to immunize subjects in a Phase IIa clinical trial of the Multimeric-001 Universal Flu Vaccine candidate. The study will evaluate the safety and immunogenicity of the Multimeric-001 vaccine.

11 Oct 2010

Philadelphia paramedics plan to sue over health coverage; healthcare merger seeks to lower costs in wash

The city's paramedics are planning to sue over Mayor Nutter's efforts to keep them out of the firefighters union. The dispute goes back to a ruling by the Pennsylvania Labor Relations Board last month that gave the city the right to shift paramedics out of the firefighters union.

11 Oct 2010

United Recovery Systems donates to Texas Children's Hospital

Employees of United Recovery Systems, LP, a leading account receivables management company, made a charitable contribution to Texas Children's Hospital, one of the top 10 pediatric hospitals in the country.

11 Oct 2010

Research reveals that fragrances can cause contact allergy

The fragrances used in many household and skincare products can cause contact allergy when exposed to oxygen in the air, reveals research from the University of Gothenburg's Faculty of Science in conjunction with the University of Gothenburg to be presented at the dermatologist conference in Gothenburg.

11 Oct 2010

UH researchers receive grant to develop Blue Scale device to track heart failure

As more and more medical care is provided in the home, health specialists say it is critical for people to be able to monitor themselves and make informed judgments about their health. A group of researchers in the Abramson Center for the Future of Health at the University of Houston (UH) received a $250,000 pre-seed grant from the Texas Emerging Technology Fund (ETF) for a system that assesses cardiac function in the home and alerts the user to the need for intervention.

11 Oct 2010

Phase-II clinical trial of MLN8237 drug shows promising results for treating ovarian cancer

A drug being developed as a treatment for ovarian cancer has shown single agent activity with durable disease control in some patients in a Phase-II clinical trial, an international research group has reported.

11 Oct 2010

First-line treatment with erlotinib drug improves progression-free survival in patients with advanced lung cancer

For patients with advanced lung cancer whose tumors carry EGFR activating mutations, first-line treatment with erlotinib nearly tripled progression-free survival compared to a standard chemotherapy combination, show results from the first prospective Phase-III study to report findings in this setting.The new results from the OPTIMAL trial were reported at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy.

11 Oct 2010

Study finds inconsistencies in methods to identify CA-BSI infection in pediatric patients

A new study looking at how hospitals identify pediatric patients who develop catheter-associated bloodstream infections (CA-BSI) found significant inconsistencies in the methods used to report the number of patients who develop them.

11 Oct 2010

Obesity can accelerate progression of acute lymphoblastic leukemia: Study

The first study to demonstrate that obesity can directly accelerate the progression of acute lymphoblastic leukemia (ALL) has been conducted at The Saban Research Institute of Childrens Hospital Los Angeles and was published in Cancer Prevention Research, on October 5, 2010.

11 Oct 2010

Researchers determine genetic structures of bacteria that cause Lyme disease

Researchers Dr. Steven E. Schutzer of UMDNJ-New Jersey Medical School and Dr. Claire M. Fraser-Liggett of the Institute for Genome Sciences, University of Maryland, and their collaborators have made a major achievement toward better understanding Lyme disease, by determining the complete genetic structures of 13 strains of the bacteria that cause the disease.

11 Oct 2010

FDA designates NeuRx Diaphragm Pacing System as HUD device for ALS patients

Synapse Biomedical Inc. announces today that they have received the U.S. Food and Drug Administration (FDA) designation of the NeuRx Diaphragm Pacing System (DPS) as a Humanitarian Use Device (HUD) for amyotrophic lateral sclerosis (ALS) patients with a stimulatable diaphragm who are experiencing chronic hypoventilation and has now submitted for Humanitarian Device Exemption (HDE) approval.

11 Oct 2010

Aetna, other insurers develop plans to help cut costs

Health insurer Aetna Inc. is developing plans to pay a major San Diego medical group enhanced fees for providing extra services to keep patients healthier, and to share any resulting cost savings.

11 Oct 2010

Cell Cure to receive equity investment of $7.1 million to develop stem cell-based therapies

BioTime, Inc. Cell Cure Neurosciences Ltd., and Hadasit Bio-Holdings Ltd. jointly announced today that Cell Cure will receive an equity investment of $7.1 million from BioTime, Teva Pharmaceutical Industries Ltd., and Hadasit Bio-Holdings (HBL).

11 Oct 2010

Cell Cure, Teva Pharmaceutical enter license option agreement for OpRegen product

BioTime, Inc., Cell Cure Neurosciences Ltd., and Hadasit Bio-Holdings Ltd. jointly announced today that Cell Cure and Teva Pharmaceutical Industries Ltd. have entered into an exclusive license option agreement to develop and commercialize Cell Cure's OpRegen product for the treatment of age-related macular degeneration (AMD).

11 Oct 2010

UBM Medica presents virtual conference for radiologists, imaging professionals

UBM Medica presented Diagnostic Imaging LIVE, a virtual conference for radiologists and imaging professionals, on September 29, 2010.

8 Oct 2010

People involved in ATV crashes are more likely to die from serious trauma: Research

In research that may surprise off-road riding enthusiasts and safety experts, a Johns Hopkins team has found that crashes involving ATVs four-wheeled all-terrain vehicles — are significantly more dangerous than crashes involving two-wheeled off-road motorcycles, such as those used in extreme sports like Motocross.

8 Oct 2010

Researchers discover rhythmic changes in synapse numbers regulate sleep cycles

With the help of tiny, see-through fish, Stanford University School of Medicine researchers are homing in on what happens in the brain while you sleep. In a new study, they show how the circadian clock and sleep affect the scope of neuron-to-neuron connections in a particular region of the brain, and they identified a gene that appears to regulate the number of these connections, called synapses.

8 Oct 2010

HHS, PEPFAR to invest $130 million to transform African medical education

The U.S. Department of Health and Human Services is partnering with the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) to invest $130 million over five years to transform African medical education and dramatically increase the number of practicing health care workers.

8 Oct 2010

GWUMC to serve as Coordinating Center for multiple NIH MEPI programs

The George Washington University Medical Center has been tapped to serve as the Coordinating Center for multiple NIH Medical Education Partnership Initiative programs and linked grantees that are focused on improving medical education and research in Sub-Saharan Africa. The five-year, $12.5 million grant awarded to GW will fund the Coordinating Center that will oversee the $130 million U.S. commitment to the program.

8 Oct 2010

Portrait painting may help children with craniofacial problems

A group of artists, young people and medical experts are involved in a groundbreaking project at The Children's Hospital of Philadelphia that uses the intimate process of portrait painting to help children and young people with craniofacial problems see themselves in a different light.

8 Oct 2010

Hospital News and Research

BiondVax commences Multimeric-001 flu vaccine Phase IIa clinical study

Philadelphia paramedics plan to sue over health coverage; healthcare merger seeks to lower costs in wash

United Recovery Systems donates to Texas Children's Hospital

Research reveals that fragrances can cause contact allergy

UH researchers receive grant to develop Blue Scale device to track heart failure

Phase-II clinical trial of MLN8237 drug shows promising results for treating ovarian cancer

First-line treatment with erlotinib drug improves progression-free survival in patients with advanced lung cancer

Study finds inconsistencies in methods to identify CA-BSI infection in pediatric patients

Obesity can accelerate progression of acute lymphoblastic leukemia: Study

Researchers determine genetic structures of bacteria that cause Lyme disease

FDA designates NeuRx Diaphragm Pacing System as HUD device for ALS patients

Aetna, other insurers develop plans to help cut costs

Cell Cure to receive equity investment of $7.1 million to develop stem cell-based therapies

Cell Cure, Teva Pharmaceutical enter license option agreement for OpRegen product

UBM Medica presents virtual conference for radiologists, imaging professionals

People involved in ATV crashes are more likely to die from serious trauma: Research

Researchers discover rhythmic changes in synapse numbers regulate sleep cycles

HHS, PEPFAR to invest $130 million to transform African medical education

GWUMC to serve as Coordinating Center for multiple NIH MEPI programs

Portrait painting may help children with craniofacial problems

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News